Using proprietary algorithms and throughput testing capabilities, Enzymit was able to develop a variety of insulin substituents and experimentally assess their functionality. Further screening resulted in several leading substituents that exhibited superior results in activity for cell culturing and required minimal concentration for activation.

Source: Enzymit and Aleph Farms partner to reduce costs of cell-based meat – FoodBev Media